Literature DB >> 12698373

[Ultrasound-guided interventions using magnetic field navigation. First experiences with Ultra-Guide 2000 under operative conditions].

M Birth1, P Iblher, P Hildebrand, J Nolde, H P Bruch.   

Abstract

AIM: Ultrasound-guided interventions are presently performed as free-hand-type procedures or using biopsy transducers. In this article we report on our experience with a new navigation-system for sonographically guided interventional procedures under OR-conditions.
METHODS: The US-Guide 2000 trade mark is an electromagnetic guidance system that assists physicians in ultrasound-guided interventional procedures. This system accommodates both in-plane and out-of-plane needle placement. We evaluated this system for the first time under OR-conditions. Overall, for 39 interventional procedures (23 thermoablations of malignant liver lesions, 16 diagnostic punctures) were performed.
RESULTS: All targets were reached successfully without any complications. No interactions with other OR-devices were seen.
CONCLUSION: The US-Guide 2000 trade mark as a virtual needle-guiding system allows a safe and accurate sonographically assisted intervention. The major advantage is the possibility of out-of-plane needle placement and the combination of flexibility of free-hand-type procedures with the accuracy of a biopsy transducer. This increases the safety of punctures especially when lesions are difficult to reach and/or are situated next to vulnerable structures. It also reduces the interventional trauma.

Entities:  

Mesh:

Year:  2003        PMID: 12698373     DOI: 10.1055/s-2003-38668

Source DB:  PubMed          Journal:  Ultraschall Med        ISSN: 0172-4614            Impact factor:   6.548


  1 in total

1.  Electromagnetic tracking for US-guided interventions: standardized assessment of a new compact field generator.

Authors:  A M Franz; K März; J Hummel; W Birkfellner; R Bendl; S Delorme; H-P Schlemmer; H-P Meinzer; L Maier-Hein
Journal:  Int J Comput Assist Radiol Surg       Date:  2012-05-24       Impact factor: 2.924

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.